
    
      A Phase I, Open-label, Randomized, Single-center, 3-way Crossover Study in Healthy Subjects
      to Evaluate the Pharmacodynamics Effects of AZD1722 Administered With and Without Food (Part
      A) plus a 2-way Crossover in Subjects to Evaluate the Pharmacodynamic Effect of AZD1722
      Administered as an AZD1722 Free-base Tablet with and without Omeprazole (Part B)
    
  